您的位置: 首页 > 2021年9月 第52卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

千伏锥形束CT(kV-CBCT)图像引导宫颈癌放射治疗的三维摆位误差分析

Three-dimensional positioning error analysis of image-guided radiation therapy for cervical cancer using kilovoltage cone-beam computed tomography

来源期刊: 广州医药 | 113-116 发布时间:2021-11-24 收稿时间:2025/11/13 18:04:05 阅读量:21
作者:
关键词:
宫颈癌影像引导千伏锥形束CT边界摆位误差
cervical cancerimage guidancekV-CBCTboundarypositioning error
DOI:
10.3969/j.issn.1000-8535.2021.05.025
收稿时间:
2021-03-10 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 利用高精确的外照射治疗技术,即图像引导放射治疗/容积旋转调强放疗(IGRT/VMAT) 时,使用千伏锥形束CT (kV-CBCT)定位来获得最佳的宫颈癌治疗获益。方法 205例接受IGRT/VMAT治疗的宫颈癌患者纳入实验组。每周做一次kV-CBCT定位后,将这些图像与计划CT扫描图像匹配后记录摆位误差。总共研究了1 025个kV-CBCT图像。采取同时期常规X片定位的90例宫颈癌患者作为对照组。根据定位中的摆位误差计算计划靶区(PTV)的边界。结果 实验组前后、上下和左右方向的摆位误差分别为(1.8±1.1)mm、(2.8±2.2)mm和(1.7±1.4)mm,对照组分别为(2.8±2.1)mm、(3.9±2.2)mm和(2.7±2.4)mm,两组差异具有统计学意义(P<0.05)。实验组前后、上下和左右方向的CTV-PTV边界分别为5.27 mm、8.54 mm和5.23 mm,对照组分别为8.47 mm、11.29 mm和8.43 mm。结论 在采用高精度技术治疗宫颈癌时,每周kV-CBCT是一种令人满意的精确定位方法,有助于减少CTV-PTV边界。
Objective To obtain the best cervical cancer treatment benefit through kilovoltage cone-beam CT (kV-CBCT) positioning, by using high-precision external beam therapy technology, that is, image-guided radiation therapy/volumetric modulated arc therapy (IGRT/VMAT). Methods Two hundred and five patients with cervical cancer treated with IGRT/VMAT were included in the experimental group. After kV-CBCT positioning once a week, these images were matched with the planned CT scan images and the setup errors were recorded. A total of 1 025 kV-CBCT images were studied. Ninety patients with cervical cancer positioned by conventional X-ray during the same period were selected as the control group. The boundary of the planned target volume (PTV) was calculated based on the setup errors. Results In the experimental group, the setup errors in the anteroposterior, superoinferior and mediolateral direction were (1.8±1.1) mm, (2.8±2.2) mm, and (1.7±1.4) mm, respectively. And in the control group, the setup errors were (2.8±2.1) mm, (3.9±2.2) mm, and (2.7±2.4) mm, respectively. The differences between the two groups were statistically significant (P<0.05). In the experimental group, the CTV-PTV boundaries in the anteroposterior, superoinferior and mediolateral direction were 5.27 mm, 8.54 mm, and 5.23 mm, respectively. And in the control group, the CTV-PTV boundaries were 8.47 mm, 11.29 mm, and 8.43 mm, respectively. Conclusion When using high-precision technology to treat cervical cancer, weekly kV-CBCT is a satisfactory and accurate positioning method, which helps to reduce the CTV-PTV boundary.
1、 TSUJII K, UEDA Y, ISONO M, et al. Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer[J]. J Radiat Res, 2021,62(4):688-698. TSUJII K, UEDA Y, ISONO M, et al. Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer[J]. J Radiat Res, 2021,62(4):688-698.
2、 CHO W K, KIM H, PARK W, et al. A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer[J]. J Radiat Res, 2021, 62 (1):149-154. CHO W K, KIM H, PARK W, et al. A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer[J]. J Radiat Res, 2021, 62 (1):149-154.
3、 DRABIK D M, MACKENZIE M A, FALLONE G B. Quantifying appropriate PTV setup margins: analysis of patient setup fidelity and intrafraction motion using post-treatment megavoltage computed tomography scans[J]. Int J Radiat Oncol Biol Phys, 2007, 68 (4):1222-1228. DRABIK D M, MACKENZIE M A, FALLONE G B. Quantifying appropriate PTV setup margins: analysis of patient setup fidelity and intrafraction motion using post-treatment megavoltage computed tomography scans[J]. Int J Radiat Oncol Biol Phys, 2007, 68 (4):1222-1228.
4、 BADAJENA A, RATURI V P, SIRVASTAVA K, et al. Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy[J]. Reports Pract Oncol Radiother, 2020, 25 (2):260-265. BADAJENA A, RATURI V P, SIRVASTAVA K, et al. Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy[J]. Reports Pract Oncol Radiother, 2020, 25 (2):260-265.
5、 LAURSEN L V, ELSTR?M U V, VESTERGAARD A, et al. Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer[J]. Radiother Oncol, 2012, 105 (2):220-225. LAURSEN L V, ELSTR?M U V, VESTERGAARD A, et al. Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer[J]. Radiother Oncol, 2012, 105 (2):220-225.
6、 MULLA Z, HASHEM RM, ALMOHAMAD A, et al. A comparison between two different immobilization devices for radiation therapy treatment of pelvic cancer using VMAT[J]. J Med Imaging Radiat Sci, 2021, S1939-8654(21)00040-0. MULLA Z, HASHEM RM, ALMOHAMAD A, et al. A comparison between two different immobilization devices for radiation therapy treatment of pelvic cancer using VMAT[J]. J Med Imaging Radiat Sci, 2021, S1939-8654(21)00040-0.
7、 HIRAI R, TAMAKI T, IGARI M, et al. Plan-optimization method for central-shielding pelvic volumetric-modulated arc therapy for cervical cancer[J]. In Vivo, 2020,34 (6):3611-3618. HIRAI R, TAMAKI T, IGARI M, et al. Plan-optimization method for central-shielding pelvic volumetric-modulated arc therapy for cervical cancer[J]. In Vivo, 2020,34 (6):3611-3618.
8、 BARSKY A R, KIM M M, DREYFUSS A, et al. Initial clinical experience treating patients with gynecologic cancers on a 6MV flattening filter free O-ring linear accelerator[J]. Adv Radiat Oncol, 2020,5 (5):920-928. BARSKY A R, KIM M M, DREYFUSS A, et al. Initial clinical experience treating patients with gynecologic cancers on a 6MV flattening filter free O-ring linear accelerator[J]. Adv Radiat Oncol, 2020,5 (5):920-928.
9、 BERNSTEIN D, TAYLOR A, NILL S, et al. New target volume delineation and PTV strategies to further personalise radiotherapy[J]. Phys Med Biol, 2021,66 (5):55024. BERNSTEIN D, TAYLOR A, NILL S, et al. New target volume delineation and PTV strategies to further personalise radiotherapy[J]. Phys Med Biol, 2021,66 (5):55024.
10、 THORWARTH D, LOW D A. Technical challenges of real-time adaptive MR-guided radiotherapy[J]. Front Oncol, 2021, 8(11):634507. THORWARTH D, LOW D A. Technical challenges of real-time adaptive MR-guided radiotherapy[J]. Front Oncol, 2021, 8(11):634507.
11、 BISTON M-C, CHIAVASSA S, GRéGOIRE V, et al. Time of PTV is ending, robust optimization comes next[J]. Cancer Radiother, 2020, 24 (6-7):676-686. BISTON M-C, CHIAVASSA S, GRéGOIRE V, et al. Time of PTV is ending, robust optimization comes next[J]. Cancer Radiother, 2020, 24 (6-7):676-686.
12、 UDAYASHANKAR A H, NOORJAHAN S, SRIKANTIA N, et al. Immobilization versus no immobilization for pelvic external beam radiotherapy[J]. Rep Pract Oncol Radiother, 2018, 23 (4):233-241. UDAYASHANKAR A H, NOORJAHAN S, SRIKANTIA N, et al. Immobilization versus no immobilization for pelvic external beam radiotherapy[J]. Rep Pract Oncol Radiother, 2018, 23 (4):233-241.
13、 YAO L, ZHU L, WANG J, LIU L, et al. Positioning accuracy during VMAT of gynecologic malignancies and the resulting dosimetric impact by a 6-degree-of-freedom couch in combination with daily kilovoltage cone beam computed tomography[J]. Radiat Oncol, 2015, 26(10):104. YAO L, ZHU L, WANG J, LIU L, et al. Positioning accuracy during VMAT of gynecologic malignancies and the resulting dosimetric impact by a 6-degree-of-freedom couch in combination with daily kilovoltage cone beam computed tomography[J]. Radiat Oncol, 2015, 26(10):104.
14、 UTENA Y, TAKATSU J, SUGIMOTO S, et al. Trajectory log analysis and cone-beam CT-based daily dose calculation to investigate the dosimetric accuracy of intensity-modulated radiotherapy for gynecologic cancer[J]. J Appl Clin Med Phys, 2021, 22 (2):108-117. UTENA Y, TAKATSU J, SUGIMOTO S, et al. Trajectory log analysis and cone-beam CT-based daily dose calculation to investigate the dosimetric accuracy of intensity-modulated radiotherapy for gynecologic cancer[J]. J Appl Clin Med Phys, 2021, 22 (2):108-117.
15、 DOHM A, SANCHEZ J, STOTSKY-HIMELFARB E, et al. Strategies to minimize late effects from pelvic radiotherapy[J]. Am Soc Clin Oncol Educ Book, 2021(41):158-168. DOHM A, SANCHEZ J, STOTSKY-HIMELFARB E, et al. Strategies to minimize late effects from pelvic radiotherapy[J]. Am Soc Clin Oncol Educ Book, 2021(41):158-168.
16、 VIANI G A, DOS SANTOS F M, PAVONI J F. Significant impact on the oncologic outcomes with intensity modulated radiotherapy and conformational radiotherapy over conventional radiotherapy in cervix cancer patients treated with radiotherapy[J]. Rep Pract Oncol Radiother, 2020, 25 (4):678-683. VIANI G A, DOS SANTOS F M, PAVONI J F. Significant impact on the oncologic outcomes with intensity modulated radiotherapy and conformational radiotherapy over conventional radiotherapy in cervix cancer patients treated with radiotherapy[J]. Rep Pract Oncol Radiother, 2020, 25 (4):678-683.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录